132 related articles for article (PubMed ID: 17921033)
1. Imaging multidrug resistance with 4-[18F]fluoropaclitaxel.
Kurdziel KA; Kalen JD; Hirsch JI; Wilson JD; Agarwal R; Barrett D; Bear HD; McCumiskey JF
Nucl Med Biol; 2007 Oct; 34(7):823-31. PubMed ID: 17921033
[TBL] [Abstract][Full Text] [Related]
2. PET imaging of multidrug resistance in tumors using 18F-fluoropaclitaxel.
Kurdziel KA; Kiesewetter DO
Curr Top Med Chem; 2010; 10(17):1792-8. PubMed ID: 20645913
[TBL] [Abstract][Full Text] [Related]
3. Human dosimetry and preliminary tumor distribution of 18F-fluoropaclitaxel in healthy volunteers and newly diagnosed breast cancer patients using PET/CT.
Kurdziel KA; Kalen JD; Hirsch JI; Wilson JD; Bear HD; Logan J; McCumisky J; Moorman-Sykes K; Adler S; Choyke PL
J Nucl Med; 2011 Sep; 52(9):1339-45. PubMed ID: 21849404
[TBL] [Abstract][Full Text] [Related]
4. Automated synthesis of 18F analogue of paclitaxel (PAC): [18F]Paclitaxel (FPAC).
Kalen JD; Hirsch JI; Kurdziel KA; Eckelman WC; Kiesewetter DO
Appl Radiat Isot; 2007 Jun; 65(6):696-700. PubMed ID: 17161952
[TBL] [Abstract][Full Text] [Related]
5. Estimation of paclitaxel biodistribution and uptake in human-derived xenografts in vivo with (18)F-fluoropaclitaxel.
Gangloff A; Hsueh WA; Kesner AL; Kiesewetter DO; Pio BS; Pegram MD; Beryt M; Townsend A; Czernin J; Phelps ME; Silverman DH
J Nucl Med; 2005 Nov; 46(11):1866-71. PubMed ID: 16269601
[TBL] [Abstract][Full Text] [Related]
6. Biodistribution, radiation dose estimates, and in vivo Pgp modulation studies of 18F-paclitaxel in nonhuman primates.
Kurdziel KA; Kiesewetter DO; Carson RE; Eckelman WC; Herscovitch P
J Nucl Med; 2003 Aug; 44(8):1330-9. PubMed ID: 12902425
[TBL] [Abstract][Full Text] [Related]
7. Noninvasive detection of multidrug resistance in patients with hematological malignancies: are we there yet?
Kostakoglu L
Clin Lymphoma; 2002 Mar; 2(4):242-8. PubMed ID: 11970764
[TBL] [Abstract][Full Text] [Related]
8. Predicting chemotherapy response to paclitaxel with 18F-Fluoropaclitaxel and PET.
Hsueh WA; Kesner AL; Gangloff A; Pegram MD; Beryt M; Czernin J; Phelps ME; Silverman DH
J Nucl Med; 2006 Dec; 47(12):1995-9. PubMed ID: 17138742
[TBL] [Abstract][Full Text] [Related]
9. In vivo and in vitro multitracer analyses of P-glycoprotein expression-related multidrug resistance.
Márián T; Szabó G; Goda K; Nagy H; Szincsák N; Juhász I; Galuska L; Balkay L; Mikecz P; Trón L; Krasznai Z
Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1147-54. PubMed ID: 12830325
[TBL] [Abstract][Full Text] [Related]
10. Metalloprobes for functional monitoring of tumour multidrug resistance by nuclear imaging.
Mendes F; Paulo A; Santos I
Dalton Trans; 2011 May; 40(20):5377-93. PubMed ID: 21384018
[TBL] [Abstract][Full Text] [Related]
11. Tetrofosmin as predictors of tumour response.
Fuster D; Viñolas N; Mallafré C; Pavia J; Martín F; Pons F
Q J Nucl Med; 2003 Mar; 47(1):58-62. PubMed ID: 12714956
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of (64)Cu(DO3A-xy-TPEP) as a potential PET radiotracer for monitoring tumor multidrug resistance.
Liu S; Kim YS; Zhai S; Shi J; Hou G
Bioconjug Chem; 2009 Apr; 20(4):790-8. PubMed ID: 19284752
[TBL] [Abstract][Full Text] [Related]
13. 64Cu-labeled phosphonium cations as PET radiotracers for tumor imaging.
Zhou Y; Liu S
Bioconjug Chem; 2011 Aug; 22(8):1459-72. PubMed ID: 21696200
[TBL] [Abstract][Full Text] [Related]
14. 99mTc-MIBI scintigraphy as a functional method for the evaluation of multidrug resistance in breast cancer patients.
Sergieva SB; Timcheva KV; Hadjiolov ND
J BUON; 2006; 11(1):61-8. PubMed ID: 17318954
[TBL] [Abstract][Full Text] [Related]
15. Assessment of 99mTc-MIBI SPECT(/CT) to monitor multidrug resistance-related proteins and apoptosis-related proteins in patients with ovarian cancer: a preliminary study.
Kurata S; Ushijima K; Kawahara A; Kaida H; Kawano K; Hirose Y; Kage M; Kamura T; Ishibashi M; Abe T
Ann Nucl Med; 2015 Aug; 29(7):643-9. PubMed ID: 25921216
[TBL] [Abstract][Full Text] [Related]
16. Nuclear medicine imaging in tuberculosis using commercially available radiopharmaceuticals.
Sathekge M; Maes A; D'Asseler Y; Vorster M; Van de Wiele C
Nucl Med Commun; 2012 Jun; 33(6):581-90. PubMed ID: 22422098
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of chemotherapeutic drug resistance in cancer therapy--a quick review.
Liu FS
Taiwan J Obstet Gynecol; 2009 Sep; 48(3):239-44. PubMed ID: 19797012
[TBL] [Abstract][Full Text] [Related]
18. Not only P-glycoprotein: Amplification of the ABCB1-containing chromosome region 7q21 confers multidrug resistance upon cancer cells by coordinated overexpression of an assortment of resistance-related proteins.
Genovese I; Ilari A; Assaraf YG; Fazi F; Colotti G
Drug Resist Updat; 2017 May; 32():23-46. PubMed ID: 29145976
[TBL] [Abstract][Full Text] [Related]
19. Imaging recognition of inhibition of multidrug resistance in human breast cancer xenografts using 99mTc-labeled sestamibi and tetrofosmin.
Liu Z; Stevenson GD; Barrett HH; Furenlid LR; Wilson DW; Kastis GA; Bettan M; Woolfenden JM
Nucl Med Biol; 2005 Aug; 32(6):573-83. PubMed ID: 16026704
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
